Byotrol (LSE:BYOT) Momentum Rank : 0 (As of May. 14, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Byotrol Momentum Rank?

Byotrol has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Byotrol Momentum Rank Related Terms

Thank you for viewing the detailed overview of Byotrol's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Byotrol (LSE:BYOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Byotrol PLC (LSE:BYOT) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

B7Y:Germany

Address

Building 303 (Ashton), Pool Lane, Thornton Science Park, Ince, Chester, GBR, CH2 4NU

Website

https://www.byotrolplc.com

Byotrol PLC is a developer of consumer and professional antimicrobial technologies and products. It is engaged in the development, patenting, licensing, and sale of anti-microbial products and technologies for business and consumer use. It operates in two reportable segments, being Professional (including Human Health, Animal Health, Facilities Management, and Food & Beverage), and Consumer (Including Household, Skin Care, and Pet Care). Its customers are based in the UK, North America, Asia, and the Rest of the World. The company generates key revenue from product sales - sale of anti-microbial technology and includes Royalty and licensing income.

Byotrol (LSE:BYOT) Headlines

No Headlines